Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Medic-All Liver Transplant Center, Kaohsiung CGMH 〉 Surgery for Hepatocellular Carcinoma

Surgery for Hepatocellular Carcinoma

Surgery for Hepatocellular Carcinoma

1.Living liver transplant recipient 1-year survival rate: 95.7%
2.Living liver transplant recipient 5-year survival rate: 90.5%

Request an appointment
Overview
Surgery is the most important therapeutic approach for patients with hepatocellular carcinoma. We have reviewed patients' survival after resection for hepatocellular carcinoma in 17 series since 2000, each including more than 100 patients. Median survival rates were 80% (range 63–97%) at 1 year, 70% (34–78%) at 3 years and 50% (17–69%) at 5 years. Such wide ranges of survival rates are attributed mainly to differences in the hepatocellular carcinoma stage among studies, but the survival rate is obviously much better for early hepatocellular carcinomas. Today, liver resection is an established treatment for hepatocellular carcinoma owing to minimal surgical mortality and improved survival. Liver transplantation is one of the best treatments for hepatocellular carcinoma in patients who meet the selection criteria. Further studies are needed to establish suitable criteria for transplantation in patients with hepatocellular carcinoma. For patients who are not candidates for liver resection or transplantation, percutaneous ablation is the best treatment option. However, no randomized controlled clinical trial has compared the results of ablation with those of surgical therapy for hepatocellular carcinoma, and none of the ablation techniques have been shown to offer a definitive survival advantage. A treatment algorithm based on published evidence is now available, which helps us to select the most suitable therapeutic option for individual patients, depending on tumor characteristics and liver functional reserve. This review paper summarizes the current status of the surgical management of hepatocellular carcinoma.
Service Procedure
People who like this also like
  • Targeting Serotonin Transporter in Neuropsychiatric Disorders with 4-[F-18]ADAM /PET Imaging Targeting Serotonin Transporter in Neuropsychiatric Disorders with 4-[F-18]ADAM /PET Imaging
  • Artificial dental implant surgery Artificial dental implant surgery
  • Extracorporeal Membrane Oxygenation (ECMO) Program/ Transport Extracorporeal Membrane Oxygenation (ECMO) Program/ Transport
  • Myasthenia gravis, diagnosis and treatment/Plasmapheresis Myasthenia gravis, diagnosis and treatment/Plasmapheresis
  • Laryngeal EMG-guided HA Injection for Unilateral Vocal Fold Paralysis Laryngeal EMG-guided HA Injection for Unilateral Vocal Fold Paralysis
  • Thulium Laser for  Prostatectomy Thulium Laser for Prostatectomy
  • Device closure of atrial septal defect Device closure of atrial septal defect
  • Health Management Service Health Management Service
  • Neuromodualation for intractable migraine Neuromodualation for intractable migraine
  • International Healthcare at Shin Kong Hospital International Healthcare at Shin Kong Hospital